Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-012918
Filing Date
2022-04-04
Accepted
2022-04-04 16:16:03
Documents
1
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3202
  Complete submission text file 0001140361-22-012918.txt   4540
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Issuer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PYXIS ONCOLOGY, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Feingold Jay (Reporting) CIK: 0001885838 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40881 | Film No.: 22802398